These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 527278)

  • 61. In vivo measurements of fibrin formation and degradation in nephrotic patients.
    Sagripanti A; Cupisti A; Baicchi U; Ferdeghini M; Barsotti G
    Int J Clin Lab Res; 1994; 24(2):113-6. PubMed ID: 7919427
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Intraglomerular deposition of coagulation-fibrinolysis factors and a platelet membrane antigen in various glomerular diseases.
    Deguchi F; Tomura S; Yoshiyama N; Takeuchi J
    Nephron; 1989; 51(3):377-83. PubMed ID: 2563903
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Clinical significance of fibrin/fibrinogen degradation products in primary glomerular disease (author's transl)].
    Kazuta Y
    Nihon Jinzo Gakkai Shi; 1978 Apr; 20(4):383-95. PubMed ID: 671857
    [No Abstract]   [Full Text] [Related]  

  • 64. Factors affecting coagulation: fibrinolysis in chronic subdural fluid collections.
    Weir B; Gordon P
    J Neurosurg; 1983 Feb; 58(2):242-5. PubMed ID: 6848682
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Decrease in renal function following decreased fibrinogen and raised fibrin degradation products in lupus nephritis with nephrotic syndrome.
    Nagayama Y; Imura H; Muso R
    Scand J Urol Nephrol; 1992; 26(4):387-91. PubMed ID: 1292078
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Relationship between urinary fibrinogen degradation products and various types of chronic nephritis.
    Sakakibara K; Nagase M; Takada Y; Takada A
    Thromb Res; 1987 Feb; 45(4):403-11. PubMed ID: 3576523
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Glomerulonephritis--nephrotic syndrome--renal vein thrombosis. Causal relationship between nephrotic syndrome and chronic renal vein thrombosis].
    Thoenes W; Anders D; Gekle D
    Klin Wochenschr; 1971 Dec; 49(24):1323-9. PubMed ID: 5138343
    [No Abstract]   [Full Text] [Related]  

  • 68. Defibrination of intraglomerular fibrin deposits by urokinase in patients with IgA nephropathy.
    Tomino Y; Miura M; Suga T; Endoh M; Nomoto Y; Sakai H
    Nihon Jinzo Gakkai Shi; 1984 Mar; 26(3):275-80. PubMed ID: 6748339
    [No Abstract]   [Full Text] [Related]  

  • 69. [Effect of physical exercise on blood and urinary FDP levels in chronic glomerulonephritis].
    Trznadel K; Lewicki R
    Pol Arch Med Wewn; 1978 Sep; 60(3):269-75. PubMed ID: 714721
    [No Abstract]   [Full Text] [Related]  

  • 70. [Serum superoxide dismutase (SOD) activity in patients with renal disease by a spintrap method using electron spin resonance (ESR)].
    Yokoyama K; Tomino Y; Yaguchi Y; Koide H; Ohmori D; Yamakura F
    Nihon Jinzo Gakkai Shi; 1993 Jul; 35(7):809-14. PubMed ID: 8411759
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Plasma soluble fibrin monomer complexes in nephrotic syndrome--with reference to hypoalbuminemia.
    Iioka Y; Kikuchi K; Tada H; Isogai S; Urayama T
    Tohoku J Exp Med; 1984 May; 143(1):53-7. PubMed ID: 6464012
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Urinary fibrinogen and fibrin fragments in children with renal disease.
    Yoshioka K; Iseki T; Akano N; Uraoka Y; Miyata H; Maki S
    Nephron; 1982; 32(2):135-9. PubMed ID: 7177290
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Thrombocyto- and coagulopathies in patients with diabetic glomerulosclerosis and chronic glomerulonephritis].
    Lapchyns'ka II; Bielyts'ka HO; Lezhen TI; Ishchenko VM; Fedorova NIe
    Lik Sprava; 1996; (3-4):74-7. PubMed ID: 9035889
    [No Abstract]   [Full Text] [Related]  

  • 74. [Therapeutic effect of defibrase in chronic glomerulonephritis with chronic renal failure].
    Wu JF; Wang SH
    Zhonghua Nei Ke Za Zhi; 1989 Mar; 28(3):171-3, 188. PubMed ID: 2805953
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [The efficacy of kurantil and its effect on thrombocytic hemostasis in patients with chronic glomerulonephritis].
    Kolesnyk MO; Lapchyns'ka II; Bielyts'ka HO
    Lik Sprava; 1994; (9-12):145-8. PubMed ID: 7604556
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [The kidney and fibrinolysis. (2) Urinary excretion of FDP].
    Taura K; Fukushima K; Shinzato K; Harada T; Ogata H
    Nihon Jinzo Gakkai Shi; 1977 Mar; 19(3):139-49. PubMed ID: 560577
    [No Abstract]   [Full Text] [Related]  

  • 77. Urinary fibrinogen degradation products and differential protein clearances in renal disease.
    Blainey JD; Terry JM
    Clin Nephrol; 1979 Mar; 11(3):140-1. PubMed ID: 436342
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Features of thrombophilia in nephrotic syndrome in children].
    Serebrianyĭ VL; Ignatova MS; Degtiareva EM; Svetlov SI
    Pediatriia; 1989; (1):49-53. PubMed ID: 2710603
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Origin of urinary fibrin/fibrinogen degradation products in glomerulonephritis.
    Ekberg M; Pandolfi M
    Br Med J; 1975 Apr; 2(5961):17-9. PubMed ID: 48398
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical significance of urinary fibrinogen degradation products in renal disease: study with two methods and correlation with histological findings of intraglomerular coagulation.
    Loschiavo C; Previato G; Valvo E; Lupo A; Tessitore N; Chiaramonte S; Maschio G
    Nephron; 1981; 28(4):200-3. PubMed ID: 7029322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.